+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Active Pharmaceutical Ingredients (API) Market 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

  • ID: 5118614
  • Report
  • February 2021
  • Region: Asia Pacific
  • 166 pages
  • GMD Research

FEATURED COMPANIES

  • AbbVie Inc.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Dr. Reddy's Laboratories
  • GlaxoSmithKline plc
  • Lupin Limited
Asia Pacific active pharmaceutical ingredients (API) market will grow by 9.0% annually with a total addressable market cap of $636.1 billion over 2021-2027 driven by the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.

Highlighted with 97 tables and 67 figures, this 166-page report “Asia Pacific Active Pharmaceutical Ingredients (API) Market 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2020 and provides forecast from 2021 till 2027 with 2020 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.

Based on Synthesis, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
  • Synthetic API
  • Branded Synthetic API
  • Generic Synthetic API
Biotech API by Drug Type:
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Other Biotech APIs
Biotech API by Customer Base:
  • Innovative Biologic API
  • Generic Biosimilar API
Biotech API by Expression Technology:
  • Mammalian Expression
  • Microbial Expression
  • Yeast Expression
  • Insect Expression
  • Other Expression Technologies
HPAPI
  • Branded HPAPI
  • Generic HPAPI
Based on Manufacturing Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.

Captive Manufacturing
  • Branded Captive API
  • Generic Captive API
Merchant Manufacturing by Drug Type:
  • Branded Merchant API
  • Generic Merchant API
Merchant Manufacturing by Drug Synthesis:
  • Merchant Synthetic API
  • Merchant Biotech API
Based on Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
  • Infectious Diseases
  • Oncology
  • Ophthalmology
  • Cardiovascular Disorders
  • Central Nervous System
  • Pulmonary Disorders
  • Orthopedics
  • Other Applications
Based on Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Drugs
Geographically, the following national/local markets are fully investigated:
  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue are available for 2017-2027. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Asia Pacific API market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Dr. Reddy's Laboratories
  • GlaxoSmithKline plc
  • Lupin Limited
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of Asia Pacific Market by Synthesis
3.1 Market Overview by Synthesis
3.2 Synthetic API
3.2.1 Branded Synthetic API
3.2.2 Generic Synthetic API
3.3 Biotech API
3.3.1 Biotech API by Drug Type
3.3.1.1 Monoclonal Antibodies
3.3.1.2 Recombinant Proteins
3.3.1.3 Vaccines
3.3.1.4 Other Biotech APIs
3.3.2 Biotech API by Customer Base
3.3.2.1 Innovative Biologic API
3.3.2.2 Generic Biosimilar API
3.3.3 Biotech API by Expression Technology
3.3.3.1 Mammalian Expression
3.3.3.2 Microbial Expression
3.3.3.3 Yeast Expression
3.3.3.4 Insect Expression
3.3.3.5 Other Expression Technologies
3.4 HPAPI
3.4.1 Branded HPAPI
3.4.2 Generic HPAPI

4 Segmentation of Asia Pacific Market by Manufacturing Process
4.1 Market Overview by Manufacturing Process
4.2 Captive Manufacturing
4.2.1 Branded Captive API
4.2.2 Generic Captive API
4.3 Merchant Manufacturing
4.3.1 Merchant Manufacturing by Drug Type
4.3.1.1 Branded Merchant API
4.3.1.2 Generic Merchant API
4.3.2 Merchant Manufacturing by Drug Synthesis
4.3.2.1 Merchant Synthetic API
4.3.2.2 Merchant Biotech API

5 Segmentation of Asia Pacific Market by Therapeutic Application
5.1 Market Overview by Therapeutic Application
5.2 Infectious Diseases
5.3 Oncology
5.4 Ophthalmology
5.5 Cardiovascular Disorders
5.6 Central Nervous System
5.7 Pulmonary Disorders
5.8 Orthopedics
5.9 Other Applications

6 Segmentation of Asia Pacific Market by Drug Type
6.1 Market Overview by Drug Type
6.2 Branded Prescription Drugs
6.3 Generic Prescription Drugs
6.4 OTC Drugs

7 Asia-Pacific Market 2020-2027 by Country
7.1 Overview of Asia-Pacific Market
7.2 China
7.3 Japan
7.4 India
7.5 Australia
7.6 South Korea
7.7 Rest of APAC Region

8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
9 Investing in Asia Pacific Market: Risk Assessment and Management
9.1 Risk Evaluation of Asia Pacific Market
9.2 Critical Success Factors (CSFs)

List of Tables
Table 1. Snapshot of Asia Pacific Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2020-2027
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Active Pharmaceutical Ingredients (API) Market
Table 5. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 6. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2017-2027, $ bn
Table 7. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2017-2027, $ bn
Table 8. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Customer Base, 2017-2027, $ bn
Table 9. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2017-2027, $ bn
Table 10. Asia Pacific Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2017-2027, $ bn
Table 11. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 12. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2017-2027, $ bn
Table 13. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2017-2027, $ bn
Table 14. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2017-2027, $ bn
Table 15. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 16. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Drug Type, 2017-2027, $ bn
Table 17. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2017-2027, $ bn
Table 18. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 19. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 20. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 21. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 22. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 23. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 24. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 25. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 26. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 27. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 28. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 29. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 30. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 31. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 32. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 33. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2017-2027, $ bn
Table 34. AbbVie Inc.: Company Snapshot
Table 35. AbbVie Inc.: Product Portfolio
Table 36. AbbVie Inc.: Revenue, 2017-2019, $ bn
Table 37. Astrazeneca: Company Snapshot
Table 38. Astrazeneca: Revenue, 2017-2019, $ bn
Table 39. Aurobindo Pharma Ltd.: Company Snapshot
Table 40. Aurobindo Pharma Ltd.: Product Portfolio
Table 41. Aurobindo Pharma Ltd.: Revenue, 2016-2020, $ INR million
Table 42. BASF: Company Snapshot
Table 43. BASF: Business Segmentation
Table 44. BASF: Revenue, 2016-2018, Euro million
Table 45. Bayer AG: Company Snapshot
Table 46. Bayer AG: Business Segmentation
Table 47. Bayer AG: Revenue, 2016-2018, € bn
Table 48. Bayer AG: Recent Developments
Table 49. Boehringer Ingelheim: Company Snapshot
Table 50. Boehringer Ingelheim: Business Segmentation in 2019
Table 51. Boehringer Ingelheim: Product Portfolio
Table 52. Boehringer Ingelheim: Revenue, 2017-2019, EUR million
Table 53. Boehringer Ingelheim: Revenue by Region in 2019
Table 54. Boehringer Ingelheim: Recent Developments
Table 55. Dr. Reddy's Laboratories: Company Snapshot
Table 56. Dr. Reddy's Laboratories: Business Segmentation
Table 57. Dr. Reddy's Laboratories: Revenue, 2018-2020, $ bn
Table 58. F. Hoffmann-La Roche: Company Snapshot
Table 59. AbbVie Inc.: Business Segmentation
Table 60. F. Hoffmann-La Roche: Revenue, 2017-2019, $ bn
Table 61. GlaxoSmithKline: Company Snapshot
Table 62. GlaxoSmithKline: Business Segmentation
Table 63. GlaxoSmithKline: Product Portfolio
Table 64. GlaxoSmithKline: Revenue, 2016-2018, $ bn
Table 65. GlaxoSmithKline: Recent Developments
Table 66. Lonza Group: Company Snapshot
Table 67. Lonza Group: Business Segmentation in 2018
Table 68. Lonza Group: Product Portfolio
Table 69. Lonza Group: Revenue, 2017-2019, $ billion
Table 70. Lonza Group: Revenue by Region in 2018
Table 71. Lonza Group: Recent Developments
Table 72. Lupin Limited: Company Snapshot
Table 73. Lupin Limited: Business Segmentation
Table 74. Lupin Limited: Revenue, 2016-2018, INR billion
Table 75. Merck & Co., Inc.: Company Snapshot
Table 76. Merck & Co., Inc.: Business Segmentation
Table 77. Merck & Co., Inc.: Revenue, 2017-2019, $ bn
Table 78. Mylan NV: Company Snapshot
Table 79. Mylan NV: Revenue, 2017-2019, $ bn
Table 80. Novartis International AG: Company Snapshot
Table 81. Novartis International AG: Business Segmentation
Table 82. Novartis International AG: Revenue, 2017-2019, $ bn
Table 83. Pfizer Inc.: Company Snapshot
Table 84. Pfizer Inc.: Business Segmentation
Table 85. Pfizer Inc.: Product Portfolio
Table 86. Pfizer Inc.: Revenue, 2016-2018, $ bn
Table 87. Pfizer Inc.: Recent Developments
Table 88. Sanofi: Company Snapshot
Table 89. Sanofi: Business Segmentation
Table 90. Sanofi: Revenue, 2017-2019, $ bn
Table 91. Sun Pharmaceutical Industries Limited: Company Snapshot
Table 92. Sun Pharmaceutical Industries Limited: Revenue, 2017-2019, INR bn
Table 93. Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 94. Teva Pharmaceutical Industries Ltd.: Business Segmentation
Table 95. Teva Pharmaceutical Industries Ltd.: Revenue, 2017-2019, $ bn
Table 96. Risk Evaluation for Investing in Asia Pacific Market, 2020-2027
Table 97. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027
Figure 5. Asia Pacific Active Pharmaceutical Ingredients (API) Market, 2020-2027, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Active Pharmaceutical Ingredients (API) Market
Figure 8. GDP per capita in the World, 1960-2018, $ thousand
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Active Pharmaceutical Ingredients (API) Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Five Forces Analysis of Asia Pacific Active Pharmaceutical Ingredients (API) Market
Figure 13. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Synthesis, 2020-2027, % of Revenue
Figure 14. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%)
Figure 15. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Synthetic API, 2017-2027, $ bn
Figure 16. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Synthetic API, 2017-2027, $ bn
Figure 17. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Synthetic API, 2017-2027, $ bn
Figure 18. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API, 2017-2027, $ bn
Figure 19. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Monoclonal Antibodies, 2017-2027, $ bn
Figure 20. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Recombinant Proteins, 2017-2027, $ bn
Figure 21. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Vaccines, 2017-2027, $ bn
Figure 22. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Biotech APIs, 2017-2027, $ bn
Figure 23. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Innovative Biologic API, 2017-2027, $ bn
Figure 24. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Biosimilar API, 2017-2027, $ bn
Figure 25. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Mammalian Expression, 2017-2027, $ bn
Figure 26. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Microbial Expression, 2017-2027, $ bn
Figure 27. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Yeast Expression, 2017-2027, $ bn
Figure 28. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Insect Expression, 2017-2027, $ bn
Figure 29. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Expression Technologies, 2017-2027, $ bn
Figure 30. Asia Pacific Active Pharmaceutical Ingredients (API) Market: HPAPI, 2017-2027, $ bn
Figure 31. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded HPAPI, 2017-2027, $ bn
Figure 32. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic HPAPI, 2017-2027, $ bn
Figure 33. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2020-2027, % of Revenue
Figure 34. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%)
Figure 35. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing, 2017-2027, $ bn
Figure 36. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Captive API, 2017-2027, $ bn
Figure 37. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Captive API, 2017-2027, $ bn
Figure 38. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing, 2017-2027, $ bn
Figure 39. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Merchant API, 2017-2027, $ bn
Figure 40. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Merchant API, 2017-2027, $ bn
Figure 41. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Synthetic API, 2017-2027, $ bn
Figure 42. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Biotech API, 2017-2027, $ bn
Figure 43. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2020-2027, % of Revenue
Figure 44. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%)
Figure 45. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Infectious Diseases, 2017-2027, $ bn
Figure 46. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Oncology, 2017-2027, $ bn
Figure 47. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Ophthalmology , 2017-2027, $ bn
Figure 48. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Cardiovascular Disorders, 2017-2027, $ bn
Figure 49. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Central Nervous System, 2017-2027, $ bn
Figure 50. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Pulmonary Disorders, 2017-2027, $ bn
Figure 51. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Orthopedics, 2017-2027, $ bn
Figure 52. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Applications, 2017-2027, $ bn
Figure 53. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Drug Type, 2020-2027, % of Revenue
Figure 54. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%)
Figure 55. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Prescription Drugs, 2017-2027, $ bn
Figure 56. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Prescription Drugs, 2017-2027, $ bn
Figure 57. Asia Pacific Active Pharmaceutical Ingredients (API) Market: OTC Drugs, 2017-2027, $ bn
Figure 58. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2020 and 2027, % of Revenue
Figure 59. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 60. Active Pharmaceutical Ingredients (API) Market in China, 2017-2027, $ bn
Figure 61. Active Pharmaceutical Ingredients (API) Market in Japan, 2017-2027, $ bn
Figure 62. Active Pharmaceutical Ingredients (API) Market in India, 2017-2027, $ bn
Figure 63. Active Pharmaceutical Ingredients (API) Market in Australia, 2017-2027, $ bn
Figure 64. Active Pharmaceutical Ingredients (API) Market in South Korea, 2017-2027, $ bn
Figure 65. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2017-2027, $ bn
Figure 66. Growth Stage of Asia Pacific Active Pharmaceutical Ingredients (API) Industry over the Forecast Period
Figure 67. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars)
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll